Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7957
DC FieldValueLanguage
dc.contributor.authorAluloski, Ien_US
dc.contributor.authorTanturovski, Men_US
dc.contributor.authorKostadinova Kunovska, Sen_US
dc.contributor.authorJovanovic Ren_US
dc.contributor.authorPetrushevska, Gordanaen_US
dc.date.accessioned2020-05-07T13:00:48Z-
dc.date.available2020-05-07T13:00:48Z-
dc.date.issued2019-11-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/7957-
dc.description.abstractIntroduction/Background The aim of the study was to evaluate the correlation between E-cadherin/β-catenin expression and the clinical and pathological parameters that influence the overall survival rate in patients with advanced stage high-grade serous ovarian/fallopian tube cancer Methodology We performed a retrospective cohort study on patients that underwent primary debulking surgery at the University Clinic of Gynecology and Obstetrics, University ‘Ss. Cyril and Methodius’, Skopje, Republic of North Macedonia between January 2010 and December 2015. The following disease characteristics were analyzed: age, stage, nuclear and tumor grade, lymphovascular invasion, the extent of primary debulking, platinum-based chemotherapy resistance and overall survival. Further, we analyzed the expression of E-cadherin/β-catenin by preforming immunohistochemical staining on deparaffinized and rehydrated tissue specimens with specific monoclonal antibodies. Results A total of 84 patients with primary ovarian and 9 patients with primary fallopian tube cancer met the inclusion criteria. The overall survival of patients in the analyzed cohort was 46 months (95% CI 38–53 months). The residual tumor volume after primary debulking surgery was an independent bad prognostic factor with HR=5.32 (p<0.001). The low frequency of expression as well as the weak staining for E-cadherin were independent bad prognostic factors for the survival of these patients with HR=2.7 (p=0.05) and HR=3.38 (p=0.04), respectively. The univariate analysis also identified that the low frequency of expression and weak staining for β-catenin were bad prognostic factors, but the significance was lost in the multivariate analysis. Conclusion In this study, we identified that the residual tumor volume after primary debulking surgery and the low frequency of expression and weak staining for E-cadherin were independent, statistically significant bad prognostic factors for the overall survival of patients with advanced stage high-grade serous ovarian/fallopian tube cancer. Beta catenin expression was not found to be an independent prognostic factor in the multivariate analysis.en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Group Ltden_US
dc.titleEP778 The role of the E-cadherin/β-catenin signal transduction pathway in the prognosis of advanced stage high-grade serous ovarian/fallopian tube canceren_US
dc.title.alternativeThe role of the E-cadherin/β-catenin signal transduction pathway in the prognosis of advanced stage high-grade serous ovarian/fallopian tube canceren_US
dc.typeProceeding articleen_US
dc.relation.conferenceePosteren_US
dc.identifier.doi10.1136/ijgc-2019-esgo.829-
dc.identifier.urlhttps://syndication.highwire.org/content/doi/10.1136/ijgc-2019-ESGO.829-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Conference papers
Show simple item record

Page view(s)

75
checked on Apr 25, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.